跳至主要内容
临床试验/EUCTR2006-006384-24-DE
EUCTR2006-006384-24-DE进行中(未招募)不适用

Bestimmung der stimulierten ß-Zell-Kapazität im oralen Nateglinide 50 g Glukose-Toleranz-Test - „Nateglinide-Test

Johan Wolfgang Goethe Universität - Department of Internal medicine I, Division Endocrinology0 个研究点开始时间: 2007年3月16日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Typ 2 Diabetes, male or female
  • Age 18 – 80 years
  • young, healthy volunteers
  • no diabetes, IFG or IGT stated in the case history
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Active, consuming diseases (cancer, HIV)
  • Renal failure (creatinine >1,5 mg/dl)
  • Liver diseases (AST, ALT >1,5x ULN)
  • Psychiatric diseases
  • Insulin therapy
  • Pregnancy or missing contraception in childbearing ange, nursing
  • contraindication to Nateglinide
  • Typ 1 diabetes
  • Unable or unwilling to comply with study
  • Maltose-Malabsorption
  • acut gastrointestinal infection
  • gut surgery in the case history

研究者

发起方
Johan Wolfgang Goethe Universität - Department of Internal medicine I, Division Endocrinology

相似试验